GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » HPC Biosciences Ltd (BOM:535217) » Definitions » Gross Profit

HPC Biosciences (BOM:535217) Gross Profit : ₹2.11 Mil (TTM As of Mar. 2023)


View and export this data going back to 2013. Start your Free Trial

What is HPC Biosciences Gross Profit?

HPC Biosciences's gross profit for the six months ended in Mar. 2023 was ₹1.09 Mil. HPC Biosciences's gross profit for the trailing twelve months (TTM) ended in Mar. 2023 was ₹2.11 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. HPC Biosciences's gross profit for the six months ended in Mar. 2023 was ₹1.09 Mil. HPC Biosciences's Revenue for the six months ended in Mar. 2023 was ₹1.09 Mil. Therefore, HPC Biosciences's Gross Margin % for the quarter that ended in Mar. 2023 was N/A%.

HPC Biosciences had a gross margin of N/A% for the quarter that ended in Mar. 2023 => No sustainable competitive advantage

During the past 12 years, the highest Gross Margin % of HPC Biosciences was 131.64%. The lowest was -11.90%. And the median was 89.55%.


HPC Biosciences Gross Profit Historical Data

The historical data trend for HPC Biosciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPC Biosciences Gross Profit Chart

HPC Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.72 10.74 20.31 -0.58 2.11

HPC Biosciences Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.20 4.08 -4.66 1.03 1.09

Competitive Comparison of HPC Biosciences's Gross Profit

For the Farm Products subindustry, HPC Biosciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HPC Biosciences's Gross Profit Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, HPC Biosciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where HPC Biosciences's Gross Profit falls into.



HPC Biosciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

HPC Biosciences's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Gross Profit (A: Mar. 2023 )=Revenue - Cost of Goods Sold
=2.111 - 0
=2.11

HPC Biosciences's Gross Profit for the quarter that ended in Mar. 2023 is calculated as

Gross Profit (Q: Mar. 2023 )=Revenue - Cost of Goods Sold
=1.085 - 0
=1.09

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹2.11 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

HPC Biosciences's Gross Margin % for the quarter that ended in Mar. 2023 is calculated as

Gross Margin % (Q: Mar. 2023 )=Gross Profit (Q: Mar. 2023 ) / Revenue (Q: Mar. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=1.09 / 1.085
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


HPC Biosciences  (BOM:535217) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

HPC Biosciences had a gross margin of N/A% for the quarter that ended in Mar. 2023 => No sustainable competitive advantage


HPC Biosciences Gross Profit Related Terms

Thank you for viewing the detailed overview of HPC Biosciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


HPC Biosciences (BOM:535217) Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 22, Pooja Complex, Office Number 109, First Floor, Veer Savarkar Block, Shakarpur, Delhi, IND, 110092
HPC Biosciences Ltd is an Indian-based company that operates in the agricultural industry. The business activity of the group includes producing and marketing agricultural products, including wheat, rice, pulses, and vegetables. Geographically operations are performed through the regions of India, and it derives revenue from the sale of products.

HPC Biosciences (BOM:535217) Headlines

No Headlines